Arun Mistry Email

Chief Medical Officer . Minoryx Therapeutics

Mataró,

Location

a******@minoryx.com

Primary Email

Current Roles

Employees:
41
Revenue:
$6.4M
About
Minoryx is a clinical stage biotech company focusing on the development of novel therapies for orphan CNS diseases with high unmet medical needs. The company's lead program, leriglitazone (MIN-102), a novel, selective PPARγ agonist, is currently being evaluated in X-ALD and Friedreich's Ataxia. The company is backed by a syndicate of experienced investors and has support from a network of other organizations. Minoryx was founded in 2011, has operations in Spain and Belgium and has raised a total of €50M through Series A & B financing rounds.
Minoryx Therapeutics Address
Av. Ernest Lluch 32, TCM2
Mataró, null
Minoryx Therapeutics Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.